149 related articles for article (PubMed ID: 36054716)
1. Correlation between catecholamines and echocardiographic parameters in patients with pheochromocytoma and paraganglioma.
Wang C; Yu Y; Yang Y
J Clin Ultrasound; 2023 Jan; 51(1):31-35. PubMed ID: 36054716
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Changes and Their Reversal Following Curative Surgery in Pheochromocytoma: PheoCard Prospective Cohort Study.
Vishvak Chanthar KMM; Khanna R; Agarwal G; Rout SR; Kapoor A; Sabaretnam M; Chand G; Mishra A; Agarwal A; Mishra SK
World J Surg; 2023 Feb; 47(2):304-311. PubMed ID: 36210362
[TBL] [Abstract][Full Text] [Related]
3. Targeting Left Ventricular Mechanics In Patients With Pheochromocytoma/Paraganglioma: An Updated Meta-analysis.
Cuspidi C; Gherbesi E; Faggiano A; Sala C; Carugo S; Grassi G; Tadic M
Am J Hypertens; 2023 May; 36(6):333-340. PubMed ID: 36617865
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
5. What is the effect of catecholamines on diastolic function in patients with pheochromocytoma and paraganglioma?
Macedo TA; Drager LF; Vieira MLC
J Clin Ultrasound; 2023 Jan; 51(1):36-37. PubMed ID: 36468283
[TBL] [Abstract][Full Text] [Related]
6. Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery.
Dobrowolski P; Januszewicz A; Klisiewicz A; Gosk-Przybyłek M; Pęczkowska M; Kabat M; Kwapiszewska A; Warchoł-Celińska E; Ambroziak U; Doroszko A; Toutounchi S; Gałązka Z; Bednarczuk T; Górnicka B; Januszewicz M; Hoffman P; Lenders JWM; Eisenhofer G; Prejbisz A
JACC Cardiovasc Imaging; 2020 Dec; 13(12):2498-2509. PubMed ID: 32950457
[TBL] [Abstract][Full Text] [Related]
7. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment.
Januszewicz M; Dobrowolski P; Januszewicz A; Warchoł-Celińska E; Jóźwik-Plebanek K; Motyl D; Kabat M; Pęczkowska M; Michałowska I; Ambroziak U; Toutounchi S; Gałązka Z; Courcelles L; Pappaccogli M; Eisenhofer G; Persu A; Lenders JWM; Kądziela J; Prejbisz A
Blood Press; 2021 Jun; 30(3):172-179. PubMed ID: 33586556
[TBL] [Abstract][Full Text] [Related]
8. Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment.
Gosk-Przybyłek M; Doroszko A; Dobrowolski P; Warchoł-Celińska E; Harazny J; Bińczyk E; Szymanek K; Pęczkowska M; Kabat M; Toutounchi S; Gałązka Z; Górnicka B; Szaflik J; Januszewicz M; Klisiewicz A; Hoffman P; Lenders JWM; Eisenhofer G; Szaflik JP; Schmieder RE; Prejbisz A; Januszewicz A
J Hypertens; 2020 Aug; 38(8):1551-1558. PubMed ID: 32205562
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and cardiac damage in pheochromocytoma and paraganglioma patients: a large-scale single-center cohort study.
Yu Y; Chen C; Meng L; Han W; Zhang Y; Zhang Z; Yang Y
BMC Cardiovasc Disord; 2024 Jun; 24(1):325. PubMed ID: 38926862
[TBL] [Abstract][Full Text] [Related]
10. Subclinical left ventricular systolic dysfunction detected by two-dimensional speckle tracking echocardiography in patients with pheochromocytoma and paraganglioma and preserved ejection fraction.
Ding L; Zhu WL; Zeng ZP; Li HZ; Ji J; Fang LG; Sun JP
Echocardiography; 2018 Feb; 35(2):184-189. PubMed ID: 29168209
[TBL] [Abstract][Full Text] [Related]
11. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
[TBL] [Abstract][Full Text] [Related]
12. [Significance of CT findings and catecholamine determination in peripheral blood of asymptomatic pheochromocytoma and paraganglioma].
Saginoya T; Miyake H; Kiyosue H; Okahara M; Hori Y; Hata H; Mori H
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jan; 61(1):33-8. PubMed ID: 11218744
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytoma/paraganglioma-associated cardiomyopathy.
Szatko A; Glinicki P; Gietka-Czernel M
Front Endocrinol (Lausanne); 2023; 14():1204851. PubMed ID: 37522121
[TBL] [Abstract][Full Text] [Related]
14. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
[TBL] [Abstract][Full Text] [Related]
15. Application of
Nakajo M; Horizoe Y; Kawaji K; Jinguji M; Tani A; Fukukura Y; Ohishi M; Yoshiura T
Jpn J Radiol; 2023 Apr; 41(4):437-448. PubMed ID: 36441441
[TBL] [Abstract][Full Text] [Related]
16. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma.
Giavarini A; Chedid A; Bobrie G; Plouin PF; Hagège A; Amar L
Heart; 2013 Oct; 99(19):1438-44. PubMed ID: 23837998
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation.
Abdul Sater Z; Jha A; Hamimi A; Mandl A; Hartley IR; Gubbi S; Patel M; Gonzales M; Taïeb D; Civelek AC; Gharib AM; Auh S; O'Mara AE; Pacak K; Cypess AM
J Clin Endocrinol Metab; 2020 Apr; 105(4):1176-85. PubMed ID: 31903484
[TBL] [Abstract][Full Text] [Related]
18. A rare association of pheochromocytoma and thoracic paraganglioma: utility of 2D contrast enhanced echocardiography.
Delgado V; Vidal B; Sitges M; Azqueta M; Pare C
Int J Cardiol; 2007 Apr; 117(2):e66-7. PubMed ID: 17320209
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases.
Kawashima A; Sone M; Inagaki N; Okamoto K; Tsuiki M; Izawa S; Otsuki M; Okamura S; Ichijo T; Katabami T; Takeda Y; Yoshimoto T; Naruse M; Tanabe A
Endocrine; 2021 Oct; 74(1):155-162. PubMed ID: 34272648
[TBL] [Abstract][Full Text] [Related]
20. The association between systolic blood pressure reduction during clonidine suppression testing and the decrease in plasma catecholamines and metanephrines.
Golani T; Fishman B; Sharabi Y; Olswang-Kutz Y; Leibowitz A; Grossman E; Shlomai G
J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1924-1931. PubMed ID: 32882089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
